Susan Dorman, MD

Faculty

Titles:

Associate Professor, Medicine

SciVal:

SciVal Link

Dr. Dorman and her research team at JHU focus on the development and assessment of new tuberculosis diagnostic tests and strategies and new tuberculosis treatment strategies.  Her team’s multidisciplinary work in tuberculosis diagnostics includes test development, accuracy assessments, implementation research, economic evaluations, and mathematical modeling.  Dr. Dorman serves as co-Principal investigator with Dr. Jerrold Ellner on a U.S. National Institutes of Health-funded contract, the ‘Tuberculosis Clinical Diagnostics Research Consortium’, whose mission is to conduct early stage assessments of novel diagnostic tests for tuberculosis at study sites in China, South Korea, South Africa, Kenya, Uganda, and Brazil.  She also serves as Principal Investigator on phase I, II, and III clinical trials of rifapentine, including multicenter international trials of the CDC Tuberculosis Trials Consortium. 

Categories

Events

«

November 2017

»
S
M
T
W
T
F
S
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
·
·

Projects

ACTG trial A5343

Phase 2 safety study of bedaquiline and delamanid for the treatment of MDR-TB in South Africa

Read More

FlexDx-TB: A flexible, user-friendly model of...

We have developed a web-based model that allows decision-makers to input local epidemiological and economic values and receive...

Read More

Modeling the impact of spatially targeted TB...

We have developed transmission models to understand the impact of TB vaccination strategies that target hotspots of...

Read More

Evaluating an automated system for...

We are evaluating the accuracy and cost-effectiveness of TBDx, an automated digital microscopy system, as a screening test to...

Read More